Regardless of these apparent positive effects, in recent studies, it has been reported that in the pathogenesis of cardiovascular disease, high levels of adiponectin do not necessarily represent better clinical outcomes [21,30], as was the case in this study. This evidence concerns the gene ADIPOQ and cardiovascular disorder.